Pharmacogenomics and Precision Medicine

Pharmacogenomics and Precision Medicine explores how genetic variations influence individual responses to drugs, enabling personalized treatment approaches. This track will cover the integration of genomic data into drug development, dosage optimization, and the prediction of adverse drug reactions. Discussions will focus on how pharmacogenomic testing can enhance the effectiveness of therapies, reduce side effects, and guide treatment decisions, ultimately advancing precision medicine to tailor interventions to each patient’s genetic profile.

 

    Related Conference of Pharmacogenomics and Precision Medicine

    January 29-30, 2026

    19th World Drug Delivery Summit

    Paris, France
    February 10-11, 2026

    40th World Congress on Pharmacology and Therapeutics

    Barcelona, Spain
    February 23-24, 2026

    3rd World Congress on Biologics and Biosimilars

    London, UK
    March 23-24, 2026

    36th Annual European Pharma Congress

    London, UK
    March 24-25, 2026

    11th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    April 16-17, 2026

    19th European Biosimilars Congress

    Rome, Italy
    April 27-28, 2026

    9th European Biopharma Congress

    Paris, Aland Islands
    May 28-29, 2026

    3rd International Conference on Pharmacognosy

    Madrid, Spain
    July 27-28, 2026

    39th World Congress on Pharmacology

    Rome, Italy
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France

    Pharmacogenomics and Precision Medicine Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in